Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
AMGN
Stock Latest News
Company Announcements
Amgen Terminates Early-Stage AMG 378 Study: What Investors Should Watch Next
16h ago
AMGN
Premium
The Fly
Evercore cuts Viridian price target, removes from ‘Tactical Outperform’ list
21h ago
AMGN
VRDN
Premium
The Fly
Zai Lab, Amgen announces trial agreement to evaluate zocilurtatug pelitecan
2d ago
AMGN
ZLAB
Premium
The Fly
FDA identifies cases of serious liver injury in patients taking Tavneos
3d ago
AMGN
Premium
The Fly
Amgen announces data on Repatha from Phase 3 Vesalius-CV trial
5d ago
AMGN
Premium
Company Announcements
Amgen’s Rocatinlimab Trial Completion Signals Next Phase for Atopic Dermatitis Strategy
9d ago
AMGN
Premium
Company Announcements
Amgen Expands Oncology Pipeline With New Phase 1 AMG 436 Study in MSI-H/dMMR Tumors
15d ago
AMGN
Premium
The Fly
Vertex Pharmaceuticals price target raised to $550 from $515 at Wells Fargo
15d ago
AMGN
REGN
Premium
The Fly
Amgen price target raised to $390 from $375 at Wells Fargo
15d ago
AMGN
REGN
Premium
Market News
Invesco QQQ Trust ETF (QQQ) Daily Update, 3/13/2026
21d ago
NDX
QQQ
Premium
Market News
Invesco QQQ Trust ETF (QQQ) Daily Update, 3/12/2026
22d ago
ZS
NDX
Premium
Market News
Invesco QQQ Trust ETF (QQQ) Daily Update, 3/11/2026
23d ago
CSX
NDX
Premium
Market News
Invesco QQQ Trust ETF (QQQ) Daily Update, 3/10/2026
24d ago
CSX
KHC
Premium
The Fly
Amgen initiated with a Hold at Jefferies
24d ago
AMGN
Premium
Market News
Invesco QQQ Trust ETF (QQQ) Daily Update, 3/5/2026
29d ago
CSX
KHC
Premium
Company Announcements
Amgen Advances Blinatumomab Franchise With New Phase 3 Subcutaneous Trial
30d ago
AMGN
Premium
Market News
Invesco QQQ Trust ETF (QQQ) Daily Update, 3/4/2026
30d ago
CSX
KHC
Premium
Market News
Invesco QQQ Trust ETF (QQQ) Daily Update, 3/3/2026
1M ago
ZS
BKR
Premium
The Fly
Kyowa Kirin announces discontinuation of rocatinlimab clinical trials
1M ago
AMGN
Premium
Company Announcements
Amgen’s Phase 3 Gout Trial Pits Subcutaneous Pegloticase Against IV Dosing
1M ago
AMGN
Premium
Market News
Invesco QQQ Trust ETF (QQQ) Daily Update, 3/2/2026
1M ago
ZS
BKR
Premium
Company Announcements
Amgen Advances Maridebart Cafraglutide Toward Mid-Stage Obesity and Liver Fat Trial
1M ago
AMGN
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
